4 active not recruiting, 2 completed, 2 unknown, 1 recruiting. 4 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 4 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Parkinson Disease, Secondary: new trials by email Literature Review of Parkinson Disease, Secondary trials Research Report on Parkinson Disease, Secondary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome Temporal Interference Stimulation - Parkinson Disease, Parkinson Disease, Secondary | Not applicable | Recruiting | Ke Dong, MD | 60 | 2026-04-21 | 2026-07-21 |
| Terazosin and Parkinson's Disease Extension Study Terazosin therapy - Symptomatic Parkinson Disease, REM Sleep Behavior Disorder | Phase 2 | Active not recruiting | Cedars-Sinai Medical Center | 15 | 2022-09-23 | 2026-03-02 |
| A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism. Case Manager, Standard-of-care - Parkinson Disease, Atypical Parkinsonism | Not applicable | Completed | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 121 | 2021-03-29 | 2026-08-31 |
| Terazosin Effect on Cardiac Changes in Early Parkinson's Disease Terazosin - REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease | Phase 2 | Active not recruiting | Cedars-Sinai Medical Center | 15 | 2020-11-01 | 2026-03-02 |
| Cardiac Changes in Early Parkinson's Disease: A Follow up Study Carvedilol - REM Sleep Behavior Disorder, Pre-motor Parkinson Disease | Phase 2 | Active not recruiting | Cedars-Sinai Medical Center | 15 | 2019-12-30 | 2026-03-02 |
| Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) Carvedilol - REM Sleep Behavior Disorder, Pre-motor Parkinson Disease | Phase 2 | Active not recruiting | Michele Tagliati, MD | 15 | 2019-04-04 | 2026-03-02 |
| Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms CoMDA associated with Neural Net 91 classificator - Primary Parkinsonism, Secondary Vascular Parkinson Disease | Completed | Ospedale Generale Di Zona Moriggia-Pelascini | 562 | 2017-01-01 | 2021-05-12 | |
| Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease Second University of Naples, Neuromed IRCCS - Parkinson Disease, Secondary | Unknown | University of Campania Luigi Vanvitelli | 100 | 2015-09-01 | 2015-10-28 | |
| Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism no intervention - Secondary Parkinsonism, Parkinson's Disease | Unknown | Corporal Michael J. Crescenz VA Medical Center | 40 | 2015-02-01 | 2018-04-05 |
Parkinson Disease (7) · REM Sleep Behavior Disorder (4) · Nerve Degeneration (2) · Primary Dysautonomias (2) · Multiple System Atrophy (1) · Supranuclear Palsy, Progressive (1)
Basal Ganglia Diseases (9) · Brain Diseases (9) · Central Nervous System Diseases (9) · Movement Disorders (9) · Nervous System Diseases (9) · Parkinsonian Disorders (9) · Neurodegenerative Diseases (7) · Synucleinopathies (7) · Mental Disorders (4) · Parasomnias (4) · REM Sleep Parasomnias (4) · Sleep Wake Disorders (4) · Autonomic Nervous System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2)
Carvedilol (2) · Case Managers (1) · Standard of Care (1) · Terazosin (1)
Cedars-Sinai Medical Center (3) · Corporal Michael J. Crescenz VA Medical Center (1) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1) · Ke Dong, MD (1) · Michele Tagliati, MD (1) · Ospedale Generale Di Zona Moriggia-Pelascini (1) · University of Campania Luigi Vanvitelli (1)
United States (5) · Italy (3) · China (1)
Michele Tagliati, MD, FAAN (2) · James Morley (1) · Michele L Lima Gregorio, MD, FAAN (1) · Michele L Tagliati, MD (1) · Paola Pedata, researcher (1) · Roberto Eleopra, MD (1)
PMID 10214756, PMID 10406987, PMID 10527042, PMID 10853813, PMID 10979878, PMID 11076832, PMID 11400186, PMID 11724917, PMID 12498954, PMID 12904089, PMID 15175402, PMID 15345186, PMID 15645531, PMID 15779234, PMID 16025231, PMID 16442563, PMID 16715205, PMID 16837857, PMID 17190953, PMID 18079166, PMID 18349024, PMID 19018276, PMID 20146689, PMID 20188504, PMID 20846908, PMID 20887968, PMID 20976736, PMID 21045744, PMID 21421334, PMID 21538520, PMID 21571570, PMID 21700495, PMID 21802993, PMID 22321865, PMID 22483040, PMID 22508280, PMID 23024438, PMID 23160999, PMID 23266935, PMID 23329524, PMID 23347909, PMID 23562390, PMID 23647842, PMID 23970363, PMID 24332912, PMID 24637128, PMID 25483722, PMID 25589269, PMID 25666029, PMID 25681454